Clin Rheumatol (2019) 38(12):333150
Eden reposted this Big news that I'm genuinely fired up about
Quick Answer: Hair loss associated with GLP-1 medications is typically temporary telogen effluvium caused by rapid weight loss rather than direct drug effects on hair follicles
For a breakdown of how results typically progress during treatment, see our Mounjaro weight-loss timeline and results guide
Moreover, the combined treatment of these two agents proved more effective than single interventions, suggesting potential synergistic effects (Mobasher et al., 2022)
ClinicalTrials.gov: NCT06383390 Reta (GLP-3) 10mg Retatrutide is an investigational multi-agonist peptide engineered to activate three metabolic hormone receptorsGLP-1, GIP, and glucagonpositioning it as a next-generation triple agonist. In research settings, it has been examined for its potential influence on appetite regulation, energy utilization, and body-weightrelated endpoints